Skip to main content
. 2015 Jul 23;10(4):1970–1978. doi: 10.3892/ol.2015.3524

Figure 4.

Figure 4.

Correlation of positive CA-IX expression with progression-free survival in patients who received adjuvant therapies following radical hysterectomy. The progression-free survival time of 35 patients with cervical cancer, who tested positive for CA-IX expression and who received the indicated adjuvant therapy after radical hysterectomy, was analyzed using the Kaplan-Meier method and a log-rank test. CA-IX, carbonic anhydrase-IX; PFS, progression-free survival.